Editorial: Digital therapeutics: using software to treat, manage, and prevent disease
- PMID: 37818169
- PMCID: PMC10561326
- DOI: 10.3389/fdgth.2023.1261124
Editorial: Digital therapeutics: using software to treat, manage, and prevent disease
Keywords: DTx; clinical tool; digital therapeutics; hardware; intervention; medical device; software; symptom monitoring.
Conflict of interest statement
LA is a paid advisor for MedRhythms. BH is the CEO of and is employed by MedRhythms and holds stock options in the company. ST is employed by MedRhythms and holds stock options in the company. KS is employed by MedRhythms and holds stock options in the company. TC is employed by Woebot Health and holds stock options in Click Therapeutics. TE has received grant funding from MedRhythms.
References
-
- SO/TR 11147:2023(en). Health informatics—Personalized digital health—Digital therapeutics health software systems. (2023). Available at: https://www.iso.org/standard/83767.html (Accessed August 15, 2023).
-
- Digital Therapeutics Alliance. What is a DTx?. Available at: https://dtxalliance.org/understanding-dtx/what-is-a-dtx/ (Accessed August 15, 2023).
Publication types
LinkOut - more resources
Full Text Sources
